Physician profile
David T Le
NPI 1861438525
$927.62
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $58.56 · 2021: $207 · 2022: $140 · 2023: $112 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $213.56 | 2021-2024 | Ozempic, Rybelsus |
| Stryker Corporation | $139.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $133.31 | 2019-2021 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Abbvie INC. | $68.70 | 2021-2024 | |
| Dexcom, INC. | $62.72 | 2021-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $51.06 | 2020-2023 | Mounjaro |
| Almatica Pharma LLC | $47.57 | 2021-2022 | |
| Glaxosmithkline, LLC. | $23.57 | 2022 | |
| Exact Sciences Corporation | $17.97 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $16.24 | 2021 | |
| Clarus Therapeutics INC. | $16.16 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.68 | 2022 | |
| Antares Pharma, INC. | $12.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.